|
Breast Cancer Remission for Sarah J. Jones
"During February 2002, I discovered a lump in my left breast that
seemed pretty big," says Sarah J. Jones of Denver, Colorado. "Because
I could not get an evaluation appointment at the Sally Jobe Diagnostic
Center in Greenwood Village, Colorado for several weeks, I researched
the holistic medical literature on my own and took a number of
nutritional supplements," Sarah says. "When finally I was seen at the
Sally Jobe Center, their multiple Doppler ultrasound films confirmed
my breast lump as potentially cancerous. The radiologist browbeat me
to have a biopsy, which I refused because of what I had learned from
my reading about the spread of cancer from biopsies.
'.With hands on hips and challenge in her voice, the head nurse at
Sally Jobe Center announced to me, 'From their star shape, I guarantee
that the cells in your breast lump are cancerous.' "If that be true,"
I wondered, "why do I need a biopsy?"
Sarah is married to cancer researcher Bob Jones, inventor of the
Cavitat@, a sonogram diagnose device tor detecting
neuralgia- inducing cavitational osteonecrosis (N(CO) arising from
implanted root canal teeth. The Cavitat@ is renowned for its
diagnostic endodontic excellence among holistic, biological,
mercury-free dentists such as those who are members of the
International Academy of Oral Medicine and Toxicology, the
Environmental Dental Association, the American Academy of Biological
Dentistry, and the Holistic Dental Association. The enlightened
dentists who are members of these professional organizations consider
Sarah and Bob Jones holistic dental visionaries.
"Not then or now do I receive physician-administered cancer treatment.
The physician who is supervising my Doppler-ultrasound evaluations,
Ob-Gyn specialist Asela C. Russell, MD, keeps insisting that I must
undergo biopsy, chemotherapy, and radiation," Sarah Jones says. "The
radiologist at the Sally .Jobe Center's Envision Department, Virgini
Stefanoudakis, MD, notes about me: 'Due to her strong beliefs in
holistic medicine, she [the patient] mayor may not agree to biopsy.'
"1
have never undergone biopsy. Near the end of May 2002, after speaking
on the phone about my breast cancer to Emmy McAllister, the director
of Health Solutions Now!, Bob learned from her about the same
anticancer substance containing minerals, vitamins, and amino acids
used successfully by Reverend Ken Walker. Then my husband did his own
literature search on the substance, Poly-MVA. Consequently, I
added this liquid amino acid metallovitamin to my nutritional
supplementation, two teaspoonfuls four times a day taken in purified
water," confirms Sarah. "I've continued this supplementation on my own
without help from any oncologist, except that Sally Jobe Center Ob-Gyn
Associate Asela C. Russell, MD, monitors the size of my tumor."
Sarah Jones concludes, "After she performed an examination of me on
November 8, 2002, Dr. Russell wrote on her prescription pad: 'Sarah
Jones' left breast mass is significantly
smaller. [Now reduced to] approximately 1.5 by 1.4 centimeters [2.1
cm3] maximum dimensions."'
Within six months of beginning her program of nutritional supplementation with Poly-MVA, this most recent oncological measurement for
the patient's cancerous breast lump shows a reduction from her
original March 15, 2002 tumor measurement of 5.382 cm3. The malignant
breast tumor of Sarah Jones had shrunk by 67 percent.
Both Sarah and Ken Walker are experiencing dramatic results from their
use of the inventor's Poly-MVA anticancer concept. The Poly-MVA name
comes from the combined terms Poly meaning ..many. much,
more than one"; M indicating "minerals"; V signifying
"vitamins"; and A symbolizing .'amino acids."
|
2) Its metallic components
activate cyanocobalamin (vitamin 812).
3) Its alpha lipoic amino acid
component aids in energy transfer within cells, which
characteristically is highly specific for transferring electron
energy from a normal metabolic hydrogen carrier to nucleic
acids.
Poly-MVA's inventor, Merrill
Garnett, DDS, PhD, emphasizes that he chose to bind palladium
(Pd) to alpha lipoic acid (ALA) because this amino acid is both
water and fat- soluble and able to travel everywhere in the
human body, even through the blood-brain barrier, taking the
palladium molecule with it.
Dr. Garnett, whose Garnett McKeen
Laboratory is located in Islip, New York, has produced a self-
published book, First Pulse: A Personal Journey in Cancer
Research. In it, the author-scientist offers a
philosophical, highly technical but interesting anecdotal-filled
discussion of how he came to create his invention. Dr. Garnett
searchedior singular substances for binding together the various
ingredients which make up Poly~MVA. He found the therapeutic
component in the platinum-derived palladium mineral, poisonous
in the hands of an allopathic dentist, but life-saving for
someone suffering from cancer. Yet Pd would be poisonous to
cancer patients too, if it were not bound tightly to alpha
lipoic acid and "sequestered" in the molecule as cobalt is
sequestered in vitamin 812. Thus, Pd forms an organic
metallovitamin-lipoic acid complex that joins with cobalt (Co),
a part of the vitamin 812 (cyanocobalamin) complex.5
Dr. Garnett created Poly-MVA
based on knowledge unknown before he discovered the Second
Genetic Code, a huge scientific breakthrough and probably the
crowning achievement of his career. (See the Garnett book for
details about the highly complicated Second Genetic Code
discovery.) |
|
The PolyMVA Anticancer Concept
, A new principle in
the nutritional
healing of most cancer types is
being presented here in the form of Poly- MVA
TM, the enzymatic complex of polynucleotide reeducates which
assists in correcting malfunctional nucleic acids in the
deoxyribonucleic acid (DNA) of genes.3
To explain: the nucleotide
component is a single building block or step up the .'spiral
staircase" of DNA. Nucleotides show up as vital units in DNA
because they are the basic molecular structures that control
cell division and replication. The reductase enzyme catalyzes
oxidation/reduction by which any substance gains one or more
electrons; and this enzyme invariably assists in bringing about
DNA repair. Subsequently, the polynucleotide reductase that is
part of the Poly-MVA molecule biochemically affects multiple
units of DNA by functioning as a gene-restoring nutrient.4
As stated, the Poly-MVA molecule
is a lipoic acid palladium (LAPd) complex, which accomplishes
such therapeutic restoration in several ways:
1) Its vitamin complex portion
improves synergy with other essential nutrients inside the
errant gene.
|
Dr. Garnett discovered that
palladium acts as an excellent catalyst for combining
oxygen (0) and hydrogen (H); the metal absorbs over 900
times its volume of hydrogen. He adapts Pd for
strengthening the actions of other molecules too; e.g.,
iron (Fe) holds together the active parts of hemoglobin,
and its holding action is reinforced in the presences of
palladium. Other amino acids besides alpha lipoic acid
make up some part of the Garnett formulation. |
|
oncologists about
chemotherapy, and acquired Poly-MVA for Mark's daily use.
I invited both Dr. Merrill Garnett and Dr. Albert Sanchez,
Sr., to lecture about it at our monthly Arizona
Homeopathic Medical Association meeting.
"While simultaneously
taking Poly- MVA and chemotherapy, my son decided to
discontinue the chemotherapy altogether because of severe
side effects he was experiencing. He therefore uses only
his regular large daily doses of Poly- MVA," Dr. Olsztyn
says. "From mid- 1998, the only contact Mark has had with
conventional oncological medicine is for diagnostic MRls.
Poly- MVA is the only treatment he has taken, and for
nearly five years there remains no visible evidence of
tumor regrowth. My son is asymptomatic and semi-annual MRI
examinations are negative for brain cancer.
"1 have recommended Poly-MVA
to many people because of my extremely favorable
impression of the Garnett concept from several viewpoints:
First, the theoretical explanation of how it works makes
sense," states Dr. Olsztyn. "Second, the product is
completely safe and definitely effective for healthy
tissue. Third, it is highly selective for malignant
tissue, by influencing oxygen, water, and electrical
inputs to the malignancy.
"Patients I've observed
taking Poly-MVA have thrived. Numbers of them are
following its protocol now. In my opinion Dr. Garnet~ and
Dr. Sanchez are providing a really well thought out, safe
treatment for all types of malignancies. They should be
commended," affirms Dr. Stanley R. Olsztyn.
Poly-MVA Eliminates Brain
Cancer for Mark Olsztyn
Now 38 years old, Mark
Olsztyn, the son of Stanley R. Olsztyn, MD(H), popular
holistic and homeopathic physician of Phoenix, Arizona,
was diagnosed in 1993 with a Stage IV frontal lobe brain
tumor the size of a walnut. After excision it was judged
to be a low-grade pilocynic astrocytoma. Recommended
follow- up was merely with periodic diagnostic Magnetic.
Resonance Imaging. The imaging was done for five years
until Mark decided he was in wonderful shape with no more
need for diagnostics.
"While working in Boston,
Mark eventually visited his local physician for a routine
checkup and a second tumor was found to have grown in the
same location of his brain. Surgery turned up that my son
now was affected by glioblastoma multiforme, a much more
serious condition than the first," explains Dr. Olsztyn.
"The tumor showed as unencapsulated, highly malignant,
growing rapidly, and infiltrating extensively. In Boston,
he took a full course of radiation therapy and then
started on chemotherapy. Realizing that he was not going
to live very long, Mark decided to return home to Phoenix
expecting to die with his loved ones around him.
"When he came back to
Phoenix in early 1998 I became an active participant in
his care," states Dr. Olsztyn. "I put him on a nutritional
program, carried on discussions with oncologists
about chemotherapy, and acquired Poly-MVA for Mark's daily
use. I invited both Dr. Merrill Garnett and Dr. Albert
Sanchez, Sr., to lecture about it at our monthly Arizona
Homeopathic Medical Association meeting.
"While simultaneously
taking Poly- MVA and chemotherapy, my son decided to
discontinue the chemotherapy altogether because of severe
side effects he was experiencing. He therefore uses only
his regular large daily doses of Poly- MVA," Dr. Olsztyn
says. "From mid- 1998, the only contact Mark has had with
conventional oncological medicine is for diagnostic MRls.
Poly- MVA is the only treatment he has taken, and for
nearly five years there remains no visible evidence of
tumor regrowth. My son is asymptomatic and semi-annual MRI
examinations are negative for brain cancer.
"1 have recommended Poly-MVA
to many people because of my extremely favorable
impression of the Garnett concept from several viewpoints:
First, the theoretical explanation of how it works makes
sense," states Dr. Olsztyn. "Second, the product is
completely safe and definitely effective for healthy
tissue. Third, it is highly selective for malignant
tissue, by influencing oxygen, water, and electrical
inputs to the malignancy.
"Patients I've observed
taking Poly-MVA have thrived. Numbers of them are
following its protocol now. In my opinion Dr. Garnet~ and
Dr. Sanchez are providing a really well thought out, safe
treatment for all types of malignancies. They should be
commended," affirms Dr. Stanley R. Olsztyn.
|
The Poly-MVA
Mechanism of Action
As reported in An
Alternative
Medicine Definitive
Guide to Cancer,
" A major factor in
the success of Poly- MVA has been to provide an
electron energy transfer mechanism from normal
metabolic hydrogen carriers to nucleic acids. Poly-MVA
induces energy-dependent changes in the shape of DNA
or ANA [ribonucleic
complex (LAPd) does
the following:8
|
1. LAPd causes
an indefinite variety of immune system
responses, but with specific manifestations as
indicated in the twelve additional attributes
listed below.
2. LAPd seeks
out and destroys cancer cells anywhere in the
body by stealing their electromagnetic energy.
3. LAPd
invigorates normal cells and helps to repair
any damage the invasive cancer may have left
behind.
4. LAPd reduces
tumor size or causes the tumor to shrink.
5. LAPd
produces an idiosyncratic set of effects which
include a pattern of lag-arrest-slow death of
cancer cells from an inhibition of their
energy metabolism.
6. LAPd
prevents sterol biosynthesis, thereby
preventing new cancer cell plasma membrane
synthesis.
7. LAPd shows a
very large fraction of sensitive cancer cells
as a morphological featur8.-- ---
8. LAPd
promotes the growth of proliferating normal
cells surrounding a core of central tumor
necrosis consisting of dead cancer cells.
9. LAPd
stimulates the infiltration of leukocytes for
the removal of cancer cell debris.
10. LAPd has
absolutely no toxic reaction -no adverse side
effects.
11. LAPd
accomplishes its therapeutic benefits in both
animals and humans.
12. LAPd works
against cancer of many types not only as an
orally administered liquid but also perhaps
even more effectively as an intravenous
injection.
13. .LAPd
reduces the incidence of cachexia with a
potential for increased body weight of the
frail cancer patient.
Being aware of
the LAPd actions in Poly-MVA, Robert D. Milne,
MD, Medical Director of the Milne Medical
Center in Las Vegas, Nevada, has employed the
metallovitamin complex for a family member and
for the adjunctive nutritional healing of
cancer in numbers of patients. He does not
treat cancer but offers his patients
nutritional support for their cancer. Poly-MVA
is one of the more vital nutrients that Dr.
Milne recommends.
"After
undergoing a full oncological evaluation, my
father-in-law at age 69 asked me to help him
with a potentially deadly 14-cm by 2.5 cm-size
Stage 3 transitional cell carcinoma 'of the
bladder producing right-ureter obstruction,"
explains Dr. Milne. "Hospitalized in a
critical care unit for ten days with acute
respiratory distress syndrome from his adverse
reaction to chemotherapy, my father- in-Iaw
was no longer a candidate for cytotoxic
therapy. Upon my educating him about Poly-MVA,
he undertook a therapeutic trial of this
nutritional agent. With the Poly-MVA, I also
recommended that he take 500 mg daily of
coenzyme 010 and 25 tablets daily of
pancreatic enzymes. The treatment proved
successful for him.
"His original
tumor biopsy taken July 2001 was reported by
the pathologist as 'invasive carcinoma Grade 2
with invasion into the muscularis propria.'
Using just the nutritional program I had
recommended," says Dr. Milne, "a report on the
six-month follow-up biopsy of my father-in-Iaw's
tumor on January 11' 2002 stated, 'There is no
cancer.' And his CAT scan showed, 'No evidence
of the tumor in this patient's bladder.'
"I believe that
the Poly-MVA adjunct for this patient was
exceedingly helpful, and the work of Dr.
Merrill Garnett is truly remarkable. It's
different from any other therapy that has ever
been done against cancer," says Dr. Robert D.
Milne. "Based on my father-in-law's excellent
result and the results experienced by many
others, I truly believe that Poly- MVA is
worth trying by any person who has cancer or
wants to prevent its onset."
|
Resources
Further
information about Merrill Garnett, PhD,
DDS, and his work in the field of bio-energetics
may be found on Dr. Garnett's website at
www.electrogenetics.com
People
wanting additional information about
Poly-MVA should visit the particular
website at www.polymva.com
Anyone
requiring a contact list of cancer
survivors who have benefited from Poly-MVA
and for a second list of over 150 health
professionals who provide patients with
Poly-MVA, should visit the survivors'
website at www. polymvasu rvivors.com
Health
professionals and others seeking
information about how to participate in
the Practitioners' Study on Poly-MVA,
may acquire a complimentary
practitioners' informational packet,
which includes Dr. Garnett's published
book, First Pulse, plus more
general material about the LAPd molecule
of Poly- MVA. Make your request to Emmy
McAllister at Health Solutions Now! ,
P.O. Box 1177, Snohomish, Washington
98291; 425-334-9644; Fax 425-334-9834;
Email: HealthSolutionsNow@earthlink.net
Ms. Emmy
McAllister is the information agent
representing the charitable organization
responsible for supporting Dr. Merrill
Garnett's metallochemical research, the
Advanced Medicine and Research Center
(AMARC), Albert Sanchez, PhD, EDS,
President, 539 Telegraph Canyon Road,
#281, Chu~a Vista, California 91910;
619-628~4751 or 619-628-4745; Fax
619-628-4749; Email: answers2cancer@
hotmail. com.
Health
professionals having more technical
biochemical/physiological questions may
telephone the inventor/ creator of Poly-MVA,
Dr. Merrill Garnett, directly at his
office in Islip, New York at
631-774-3821.
Persons
wishing to acquire a supply of oral
Poly-MVA and other nutritional
substances may contact the primary
commercial source in North America,
AMARC Enterprises, Inc., Albert Sanchez,
Jr., President; 866-Poly-MVA i.e.
866-765-9682; Email: info@polymva.com.
|
For
further information about this
multiple myeloma remission
experience, contact Reverend Ken
Walker, 221 Bella Vista Drive, Fox
Island, Washington 98333; 253-549-
7676; Email: kwalk@centurytel.net
For
further information about her
breast cancer reduction
experience, contact Sarah Jones,
Cavitat Medical Tech Inc., 10691
East Bethany Drive, Suite 900,
Aurora, Colorado 80014- 2670;
303-755-2688.
For
further information about therapy
for his son Mark or other patients
taking the Poly-MVA, contact
Stanley R. Olsztyn, MD, 4350 East
Camelback Road, Suite B-220,
Phoenix, Arizona 85018; 602-840-
8424; Email: srolsztyn@aol.com
For
further information about his
experience administering Poly-MVA
and the adaptation of Dr. Rudy
Falk's original protocol, contact
Ahmed Nasri, MD, 730 Essa Road,
Barrie, Ontario, Canada L4N 9E9;
Tel. 705- 735-2354; Email: ncim@hotmail.com.
For
further information about his
experience with the IV injection
of Poly-MVA, contact David C.
Korn, D.O., D.D.S., M.D.(H), Long
Life Medical Incorporated, 11518
East Apache Trail, Suite 115,
Apache Junction, Arizona 85220;
480-354- 6700; Email
longlifemedical @ msn. com.
For
his summary judgment about the
anticancer qualities of Poly-MVA,
contact Robert D. Milne, M.D.,
Medical Director of the Milne
Medical Center, 2110 Pinto Lane,
Las Vegas, Nevada 89106;
702-385-1393; Email: mmc@ivcm.ccim. |
|
|
|
|
|
|